2021 Global Drug Bioavailability Enhancement Summit

March 2nd – 4th, 2021 | San Diego, CA
Gather insights into the latest technologies and methods of new drug formulation and bioavailability enhancement strategies.

About

2021 Global Drug Bioavailability Enhancement Summit

It’s no lie the drug development model is in need of a drastic shakeup. With lengthy and costly approval processes, generic incursion, rising development costs and the need for novel adherence strategies, pharma and biotech, now more than ever need to initiate innovative formulation, delivery and development approaches in order to improve bioavailability and therapeutic performance.

We’re here to help. The 2021 Global Drug Bioavailability Enhancement Summit will connect industry leaders from both small molecule and biologics areas to address challenges at the interface between drug discovery and preclinical/clinical development. 2021’s Summit will share cutting edge research on the development, characterization and manufacture of formulations that span multiple modalities. Hear from 30+ senior drug bioavailability pioneers and network with 120+ senior drug development innovators and walk away with over 2 years of new drug formulation and bioavailability enhancement approaches strategies in just 2 days!

Are you looking to improve drug performance, bioavailability and patient adherence? Would you like to reduce dosage, cost and time-to-market? Get involved today at the 2021 Summit and dramatically increase the performance and activity of your current and future drug products.

30+

Industry-led Speakers

120+

Senior Participants

14+

Networking Hours

16

Tech Exhibitors

You Will Learn

Precision medicine & healthcare delivery
Rationale formulation design for poorly soluble compounds
In-vivo – in-vitro correlation
Solution behavior of amorphous solid dispersions
Nanosuspension for improving the bioavailability
Early formulation screening in drug discovery
3D printing for biopharmaceuticals
Enhancing patient adherence via drug delivery
Innovative strategies around drug / device combinations

Would You Like To Improve Drug Performance?

Attend and walk away with 2 YEARS worth of new product development strategies, formulation approaches, delivery technologies and regulatory updates while decreasing drug product time-to-market in just 3 days!

Stay Up To Date With The Latest Updates and Event Info

Pricing

Early-Bird

Conference Only

$1,295

Conference + 1 Workshop

$1,495

Standard Pricing

Conference Only

$2,095

Conference + 1 Workshop

$2,295

Onsite Pricing

Conference Only

$2,295

Conference + 1 Workshop

$2,495

Commercial Advances in Drug Delivery Systems for Peptide-Based Therapeutics

Beyond 2020, the global Peptide Therapeutics market is expected to eclipse $42 billion. This dramatic market increase is driven by both growing incidences of cardiovascular and metabolic diseases, and technological enhancements in peptide synthesis that include...

Understanding the Importance of Excipient Selection for Controlled Release

Controlled delivery formulations remain one of the favored tools for advancing the lifecycle of pharmaceutical products. A traditional strategy is to initially launch multiple daily doses of an immediate-release (IR) product, then reformulate into a once-daily...

Why Should you Consider Developing Controlled and Modified-Release Drug Products?

There are a number of pharmacological and economical benefits to developing controlled and modified release drug products. Following the 505(b)(2) pathway allows companies to make modest changes to an already approved drug and get continued market exclusivity for a...